News

State sues AI company after bot impersonates doctor

The digital entity gave at least one end-user a phony medical-license number. Unfortunately for the chatbot, that end-user was a state investigator.

Cannabis use increases risk of death, heart attack for ED patients

When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.

Kevin Accola, MD, a cardiac surgeon at Advent Health in Orlando, Florida, explains the 10-year results from the COMMENCE aortic trial that shows long-term durability and sustained performance of its Resilia surgical aortic valve. The data were presented at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. #AATS #AATS26 #AATS2026

Resilia tissue developed by Edwards Lifesciences associated with long-term durability

Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.

CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.

CCTA brings clarity, better outcomes to CTO PCI

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

Physicians chime in: Coronary plaque staging offers more precise cardiac patient management

As precision cardiology continues to evolve, the integration of advanced coronary computed tomography angiography (CCTA) and AI-driven analysis is fundamentally changing how we assess and manage coronary artery disease (CAD). Here is a closer look at how Heartflow Plaque Staging is leveraging Total Plaque Volume (TPV) to stratify patient risk.

Society of cardiovascular computed tomography (SCCT) President Kavitha Chinnaiyan, MD, FACC, MSCCT, a cardiologist and professor of medicine at Oakland University William Beaumont School of Medicine in Royal Oak, with is part of Corewell Health, explains some of the key trends in coronary computed tomography angiography (CCTA) and how this is being translated into educational programming at the SCCT 2026 annual scientific meeting (ASM). #SCCT2026

SCCT President: Key trends in cardiac CT

As CCTA sees rapid adoption across cardiology, SCCT is working to address the education required to sustain the expansion.

Anthem Elebance blue cross blue shield bcbs

Hospitals sue Anthem over policy prohibiting use of out-of-network radiologists

Anthem defended the policy in response to the lawsuit, contending patients shouldn’t have to worry about surprise medical bills when visiting in-network hospitals.

American College of Radiology Council approves ‘groundbreaking’ framework for assessing AI

Leaders voted to OK the new Practice Parameter for Imaging Artificial Intelligence during ACR’s annual meeting, being held in Washington, D.C.

Patients in rural communities struggle to access newer tumor-targeting radiotracers

In some cases, patients in isolated areas must travel up to 130 miles to gain access to the latest class of NETs, new data suggest.

overweight patient seeking health advice

FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs

The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal.

Endometriosis radiotracer performs well at clinical trial

Investigational radiotracer has 'extremely valuable' potential for treating chronic condition

New findings suggest that 99mTc-maraciclatide can help physicians more accurately identify endometriosis on imaging.

FDA recall medical device recall product recall

FDA announces recall on insulin pump pods after leaks cause 29 serious injuries

Some Omnipod 5 devices, manufactured by Insulet, are subject to the Class I recall. The products with the defect must be removed from where they are used or sold to ensure safety, as lower-than-expected insulin doses could have potentially lethal repercussions.

Around the web

Health Exec